Severe
acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is
still spreading around the globe causing immense public health and
socioeconomic problems. As the infection can progress with mild symptoms
that can be misinterpreted as the flu, self-testing methods that can
positively identify SARS-CoV-2 are needed to effectively track and
prevent the transmission of the virus. In this work, we report a point-of-care
toolkit for multiplex molecular diagnosis of SARS-CoV-2 and influenza
A and B viruses in saliva samples. Our assay is physically programmed
to run a sequence of chemical reactions on a paper substrate and internally
generate heat to drive these reactions for an autonomous extraction,
purification, and amplification of the viral RNA. Using our assay,
we could reliably detect SARS-CoV-2 and influenza viruses at concentrations
as low as 50 copies/μL visually from a colorimetric analysis.
The capability to autonomously perform a traditionally labor-intensive
genetic assay on a disposable platform will enable frequent, on-demand
self-testing, a critical need to track and contain this and future
outbreaks.